APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bone and Joint Health Ingredients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bone and Joint Health Ingredients Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchBone and Joint Health Ingredients Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Bone and Joint Health Ingredients Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Bone and Joint Health Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bone and Joint Health Ingredients Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bone and Joint Health Ingredients Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Bone and Joint Health Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bone and Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bone and Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bone and Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bone and Joint Health Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bone and Joint Health Ingredients market include Archer Daniels Midland, DowDuPont, Rousselot, Royal DSM, Synutra and Waitaki Bio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bone and Joint Health Ingredients market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bone and Joint Health Ingredients and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bone and Joint Health Ingredients revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bone and Joint Health Ingredients market.

Bone and Joint Health Ingredients Segment by Company

Archer Daniels Midland

DowDuPont

Rousselot

Royal DSM

Synutra

Waitaki Bio

Bone and Joint Health Ingredients Segment by Type

Chondroitin

Omega-3

Collagen

Glucosamine

MSM (methylsulfonylmethane)

Others

Bone and Joint Health Ingredients Segment by Application

Pharmaceuticals

Supplements

Others

Bone and Joint Health Ingredients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bone and Joint Health Ingredients status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bone and Joint Health Ingredients key companies, revenue, market share, and recent developments.

3. To split the Bone and Joint Health Ingredients breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bone and Joint Health Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bone and Joint Health Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze Bone and Joint Health Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone and Joint Health Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bone and Joint Health Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone and Joint Health Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone and Joint Health Ingredients industry.

Chapter 3: Detailed analysis of Bone and Joint Health Ingredients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bone and Joint Health Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bone and Joint Health Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bone and Joint Health Ingredients Industry Trends Table 2. Bone and Joint Health Ingredients Industry Drivers Table 3. Bone and Joint Health Ingredients Industry Opportunities and Challenges Table 4. Bone and Joint Health Ingredients Industry Restraints Table 5. Global Bone and Joint Health Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bone and Joint Health Ingredients Revenue Share by Company (2021-2026) Table 7. Global Bone and Joint Health Ingredients Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bone and Joint Health Ingredients Key Company Manufacturing Base & Headquarters Table 9. Global Bone and Joint Health Ingredients Company, Product Type & Application Table 10. Global Bone and Joint Health Ingredients Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bone and Joint Health Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chondroitin Table 15. Significant Companies of Omega-3 Table 16. Significant Companies of Collagen Table 17. Significant Companies of Glucosamine Table 18. Significant Companies of MSM (methylsulfonylmethane) Table 19. Significant Companies of Others Table 20. Global Bone and Joint Health Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Bone and Joint Health Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Bone and Joint Health Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Bone and Joint Health Ingredients Sales Value Share by Type (2021-2026) Table 24. Global Bone and Joint Health Ingredients Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Pharmaceuticals Table 26. Significant Companies of Supplements Table 27. Significant Companies of Others Table 28. Global Bone and Joint Health Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Bone and Joint Health Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Bone and Joint Health Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Bone and Joint Health Ingredients Sales Value Share by Application (2021-2026) Table 32. Global Bone and Joint Health Ingredients Sales Value Share by Application (2027-2032) Table 33. Global Bone and Joint Health Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bone and Joint Health Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Bone and Joint Health Ingredients Sales Value Share by Region (2021-2026) Table 36. Global Bone and Joint Health Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Bone and Joint Health Ingredients Sales Value Share by Region (2027-2032) Table 38. Global Bone and Joint Health Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bone and Joint Health Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Bone and Joint Health Ingredients Sales Value Market Share by Country (2021-2026) Table 41. Global Bone and Joint Health Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Bone and Joint Health Ingredients Sales Value Market Share by Country (2027-2032) Table 43. Archer Daniels Midland Company Information Table 44. Archer Daniels Midland Business Overview Table 45. Archer Daniels Midland Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Archer Daniels Midland Bone and Joint Health Ingredients Product Portfolio Table 47. Archer Daniels Midland Recent Development Table 48. DowDuPont Company Information Table 49. DowDuPont Business Overview Table 50. DowDuPont Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. DowDuPont Bone and Joint Health Ingredients Product Portfolio Table 52. DowDuPont Recent Development Table 53. Rousselot Company Information Table 54. Rousselot Business Overview Table 55. Rousselot Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Rousselot Bone and Joint Health Ingredients Product Portfolio Table 57. Rousselot Recent Development Table 58. Royal DSM Company Information Table 59. Royal DSM Business Overview Table 60. Royal DSM Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Royal DSM Bone and Joint Health Ingredients Product Portfolio Table 62. Royal DSM Recent Development Table 63. Synutra Company Information Table 64. Synutra Business Overview Table 65. Synutra Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Synutra Bone and Joint Health Ingredients Product Portfolio Table 67. Synutra Recent Development Table 68. Waitaki Bio Company Information Table 69. Waitaki Bio Business Overview Table 70. Waitaki Bio Bone and Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Waitaki Bio Bone and Joint Health Ingredients Product Portfolio Table 72. Waitaki Bio Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Bone and Joint Health Ingredients Product Image Figure 2. Global Bone and Joint Health Ingredients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bone and Joint Health Ingredients Market Size (2021-2032) & (US$ Million) Figure 4. Global Bone and Joint Health Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chondroitin Image Figure 8. Omega-3 Image Figure 9. Collagen Image Figure 10. Glucosamine Image Figure 11. MSM (methylsulfonylmethane) Image Figure 12. Others Image Figure 13. Global Bone and Joint Health Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Bone and Joint Health Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Bone and Joint Health Ingredients Sales Value Share by Type (2021-2032) Figure 16. Pharmaceuticals Image Figure 17. Supplements Image Figure 18. Others Image Figure 19. Global Bone and Joint Health Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bone and Joint Health Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Bone and Joint Health Ingredients Sales Value Share by Application (2021-2032) Figure 22. Global Bone and Joint Health Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Bone and Joint Health Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Bone and Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 25. North America Bone and Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Bone and Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Bone and Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Bone and Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Bone and Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Bone and Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 31. South America Bone and Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Bone and Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Bone and Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Chondroitin
  • Omega-3
  • Collagen
  • Glucosamine
  • MSM (methylsulfonylmethane)
  • Others
Applications
  • Pharmaceuticals
  • Supplements
  • Others
Companies covered
  • Archer Daniels Midland
  • DowDuPont
  • Rousselot
  • Royal DSM
  • Synutra
  • Waitaki Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bone and Joint Health Ingredients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bone and Joint Health Ingredients Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bone and Joint Health Ingredients Market Dynamics
  1. 2.1 Bone and Joint Health Ingredients Industry Trends
  2. 2.2 Bone and Joint Health Ingredients Industry Drivers
  3. 2.3 Bone and Joint Health Ingredients Industry Opportunities and Challenges
  4. 2.4 Bone and Joint Health Ingredients Industry Restraints
3 Bone and Joint Health Ingredients Market by Company
  1. 3.1 Global Bone and Joint Health Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global Bone and Joint Health Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global Bone and Joint Health Ingredients Company Ranking (2024-2026)
  4. 3.4 Global Bone and Joint Health Ingredients Company Manufacturing Base and Headquarters
  5. 3.5 Global Bone and Joint Health Ingredients Company Product Type and Application
  6. 3.6 Global Bone and Joint Health Ingredients Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bone and Joint Health Ingredients Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bone and Joint Health Ingredients Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bone and Joint Health Ingredients Market by Type
  1. 4.1 Bone and Joint Health Ingredients Type Introduction
  2. 4.1.1 Chondroitin
  3. 4.1.2 Omega-3
  4. 4.1.3 Collagen
  5. 4.1.4 Glucosamine
  6. 4.1.5 MSM (methylsulfonylmethane)
  7. 4.1.6 Others
  8. 4.2 Global Bone and Joint Health Ingredients Sales Value by Type
  9. 4.2.1 Global Bone and Joint Health Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Bone and Joint Health Ingredients Sales Value by Type (2021-2032)
  11. 4.2.3 Global Bone and Joint Health Ingredients Sales Value Share by Type (2021-2032)
5 Bone and Joint Health Ingredients Market by Application
  1. 5.1 Bone and Joint Health Ingredients Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Supplements
  4. 5.1.3 Others
  5. 5.2 Global Bone and Joint Health Ingredients Sales Value by Application
  6. 5.2.1 Global Bone and Joint Health Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bone and Joint Health Ingredients Sales Value by Application (2021-2032)
  8. 5.2.3 Global Bone and Joint Health Ingredients Sales Value Share by Application (2021-2032)
6 Bone and Joint Health Ingredients Regional Value Analysis
  1. 6.1 Global Bone and Joint Health Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bone and Joint Health Ingredients Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bone and Joint Health Ingredients Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bone and Joint Health Ingredients Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bone and Joint Health Ingredients Sales Value (2021-2032)
  7. 6.3.2 North America Bone and Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bone and Joint Health Ingredients Sales Value (2021-2032)
  10. 6.4.2 Europe Bone and Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bone and Joint Health Ingredients Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bone and Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bone and Joint Health Ingredients Sales Value (2021-2032)
  16. 6.6.2 South America Bone and Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bone and Joint Health Ingredients Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bone and Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
7 Bone and Joint Health Ingredients Country-level Value Analysis
  1. 7.1 Global Bone and Joint Health Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bone and Joint Health Ingredients Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bone and Joint Health Ingredients Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bone and Joint Health Ingredients Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bone and Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bone and Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bone and Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Archer Daniels Midland
  2. 8.1.1 Archer Daniels Midland Company Information
  3. 8.1.2 Archer Daniels Midland Business Overview
  4. 8.1.3 Archer Daniels Midland Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Archer Daniels Midland Bone and Joint Health Ingredients Product Portfolio
  6. 8.1.5 Archer Daniels Midland Recent Developments
  7. 8.2 DowDuPont
  8. 8.2.1 DowDuPont Company Information
  9. 8.2.2 DowDuPont Business Overview
  10. 8.2.3 DowDuPont Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DowDuPont Bone and Joint Health Ingredients Product Portfolio
  12. 8.2.5 DowDuPont Recent Developments
  13. 8.3 Rousselot
  14. 8.3.1 Rousselot Company Information
  15. 8.3.2 Rousselot Business Overview
  16. 8.3.3 Rousselot Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Rousselot Bone and Joint Health Ingredients Product Portfolio
  18. 8.3.5 Rousselot Recent Developments
  19. 8.4 Royal DSM
  20. 8.4.1 Royal DSM Company Information
  21. 8.4.2 Royal DSM Business Overview
  22. 8.4.3 Royal DSM Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Royal DSM Bone and Joint Health Ingredients Product Portfolio
  24. 8.4.5 Royal DSM Recent Developments
  25. 8.5 Synutra
  26. 8.5.1 Synutra Company Information
  27. 8.5.2 Synutra Business Overview
  28. 8.5.3 Synutra Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Synutra Bone and Joint Health Ingredients Product Portfolio
  30. 8.5.5 Synutra Recent Developments
  31. 8.6 Waitaki Bio
  32. 8.6.1 Waitaki Bio Company Information
  33. 8.6.2 Waitaki Bio Business Overview
  34. 8.6.3 Waitaki Bio Bone and Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Waitaki Bio Bone and Joint Health Ingredients Product Portfolio
  36. 8.6.5 Waitaki Bio Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst